ORKAOruka Therapeutics Inc. Common Stock
107.96USD-1.58%Mkt Cap: 7.15B $P/E: —3d ago
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead pr…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap7.15B $
Enterprise Value6.07B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-105.43M $
Revenue/Share—
Last Price107.96 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees68
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-37.83
PEG—
EV/EBITDA-39.21
EV/Revenue—
P/S—
P/B5.76
EPS (TTM)-1.95
EPS (Forward)-2.77
52W Range
14.0893% of range115.51
52W High115.51 USD
52W Low14.08 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-22.48%
ROA-21.58%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-88.21M $
CapEx (TTM)209.00K $
FCF Margin—
FCF Yield-0.91%
Net Debt-871.02M $
Net Debt/EBITDA5.62
Balance Sheet
Debt/Equity0.00
Current Ratio38.51
Quick Ratio38.03
Book Value/Sh18.20 USD
Cash/Share13.19 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 28, 2024
Splits
Last Split1:12
Split DateSep 3, 2024
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)153.75 USD
Upside (mean)+42.4%
Target Range102.00 USD – 200.00 USD
$102.00+42.4% to mean$200.00
# Analysts12
Ownership
Shares Out.66.21M
Float56.98M
Insiders1.11%
Institutions116.50%
Short Interest
Short Ratio6.7d
Short % Float17.71%
Short % Out.12.16%
Shares Short8.05M
Short (prev mo.)9.16M
Technical
SMA 5090.55 (+19.2%)
SMA 20054.41 (+98.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)826.78K
Avg Vol (10d)787.72K
Technical Indicators
RSI (14)65.2
MACD6.2980
MACD Signal5.8121
MACD Hist.+0.4859
BB Upper115.44 USD
BB Middle100.06 USD
BB Lower84.68 USD
BB Width30.74%
ATR (14)5.522 USD
Vol Ratio (20d)1.10x